Skip to content

The Role of Indocyanine Green Angiography Fluorescence on Intestinal Resections in Pediatric Surgery.

The Role of Indocyanine Green Angiography Fluorescence on Intestinal Resections in Pediatric Surgery.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04020939
Enrollment
35
Registered
2019-07-16
Start date
2020-03-16
Completion date
2021-03-10
Last updated
2021-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroschisis, Hirschsprung Disease, Incarcerated Hernia, Intestinal Atresia, Intestinal Obstruction, Intestinal Perforation, Intussusception, Malrotation, Meconium Ileus, Necrotizing Enterocolitis, Trauma, Volvulus

Keywords

SPY imaging, indocyanine green, pediatric surgery, ICG, intestinal resections, intestinal perfusion

Brief summary

Background: Intestinal resections are commonly performed in the pediatric population. Perfusion of the bowel is one of the most important factors determining the viability of an intestinal anastomosis. Up to date, no ideal method to assess intestinal perfusion has proven its superiority. Objectives: Primary: The aim of this study is to establish the feasibility and impact of the use of indocyanine green technology on intestinal resection margins during elective and emergency pediatric surgeries. Secondary: The secondary outcomes of interest include collection of adverse events and difficulties encountered with the use of the indocyanine green (ICG) technology. Postoperative surgical complications will also be recorded. Study Design: An open observational clinical study will be performed by using a clinical drug (indocyanine green) and medical device (SPY Fluorescence Imaging) to assess intraoperatively intestinal perfusion in a specific pediatric population.

Interventions

Use of the SPY Pinpoint imaging device to evaluate intraoperative intestinal perfusion in children.

DRUGIndocyanine Green

Intravenous injection of indocyanine green to evaluate the intestinal perfusion.

Sponsors

St. Justine's Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
0 Years to 16 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients \< 16 years old * Admitted between September 2019 and September 2020 * Patients undergoing a surgery at CHUSJ * Any diagnosis requiring intra-abdominal intestinal resection (including stoma reversal) * Written informed consent form from the parents or legal guardian

Exclusion criteria

* Patients \> 16 years old * Patients with known allergy or sensitivity to iodine * Patients with known kidney or liver failure * Patients with known severe cardiac or pulmonary diseases * Informed consent unobtained or impossible due to refusal of parents, language barrier, or diminished comprehension

Design outcomes

Primary

MeasureTime frameDescription
SPY System utility in intestinal resections in Pediatric Surgery1 yearTo demonstrate the utility of intra-operative evaluation of intestinal viability using the SPY Fluorescence Imaging System to optimize the location of the resection margins in pediatric surgeries necessitating intestinal resections. \- Rate of intestinal resection margins modifications by using the SPY technology

Secondary

MeasureTime frameDescription
Length of stay1 yearIn days
Operative time30 daysIn minutes
Surgical complications1 year* Number of anastomotic leaks * Number of strictures * Number of bowel obstructions
Need for additional reoperations1 yearNumber
Need for additional radiology interventions1 yearNumber
Estimated blood losses30 daysIn ml

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026